1. Home
  2. AGBK vs DAWN Comparison

AGBK vs DAWN Comparison

Compare AGBK & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AGBK

AGI Inc Class A Common Shares

N/A

Current Price

$9.89

Market Cap

1.9B

Sector

Finance

ML Signal

N/A

Logo Day One Biopharmaceuticals Inc.

DAWN

Day One Biopharmaceuticals Inc.

HOLD

Current Price

$21.31

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGBK
DAWN
Founded
1999
2018
Country
Brazil
United States
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.2B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
AGBK
DAWN
Price
$9.89
$21.31
Analyst Decision
Strong Buy
Buy
Analyst Count
5
10
Target Price
$17.20
$26.00
AVG Volume (30 Days)
524.5K
5.8M
Earning Date
01-01-0001
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$158,182,000.00
Revenue This Year
N/A
$53.52
Revenue Next Year
$6.64
$27.10
P/E Ratio
$46.19
N/A
Revenue Growth
N/A
20.60
52 Week Low
$9.00
$5.64
52 Week High
$12.21
$21.40

Technical Indicators

Market Signals
Indicator
AGBK
DAWN
Relative Strength Index (RSI) 38.95 81.71
Support Level $9.00 $6.45
Resistance Level $12.12 $21.40
Average True Range (ATR) 0.52 0.45
MACD -0.20 0.74
Stochastic Oscillator 28.48 99.21

Price Performance

Historical Comparison
AGBK
DAWN

About AGBK AGI Inc Class A Common Shares

AGI Inc is a technology-powered provider of specialized financial services in Brazil. It empowers clients to access their social security benefits, severance fund benefits, and public or private sector payrolls through secured lending solutions and complementary banking, credit and insurance products tailored as per client needs. The company has one operating segment related to the banking business. The Bank provides a standardized set of financial products and services exclusively to individuals, mainly focused on credit, including digital accounts, cards, payroll and personal loans, and insurance offered through partners.

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY301 is an antibody drug conjugate (ADC) that has shown antitumor activity in preclinical models.

Share on Social Networks: